Number of the records: 1
HPMA copolymer mebendazole conjugate allows systemic administration and possesses antitumour activity in vivo
- 1.STUDENOVSKÝ, Martin, RUMLEROVÁ, Anna, KOVÁŘOVÁ, Jiřina, DVOŘÁKOVÁ, Barbora, SIVÁK, Ladislav, KOSTKA, Libor, BERDÁR, Daniel, ETRYCH, Tomáš, KOVÁŘ, Marek. HPMA copolymer mebendazole conjugate allows systemic administration and possesses antitumour activity in vivo. Pharmaceutics. 2022, 14(6), 1201. E-ISSN 1999-4923. Available: doi: 10.3390/pharmaceutics14061201.
Number of the records: 1